Related Experiment Video
Updated: Jun 13, 2025
09:18
Intraventricular Drug Delivery and Sampling for Pharmacokinetics and Pharmacodynamics Study
Published on: March 31, 2022
2.6K
A Bayesian pharmacokinetics integrated phase I-II design to optimize dose-schedule regimes
Mengyi Lu1, Ying Yuan2, Suyu Liu2
1Department of Biostatistics, Nanjing Medical University, Nanjing 211166, China.
Biostatistics (Oxford, England)
|September 14, 2024
Summary
Optimizing drug administration schedules is crucial for balancing efficacy and toxicity. This study introduces a Bayesian approach integrating pharmacokinetics (PK), toxicity, and efficacy to find optimal dose-schedule regimens, improving patient outcomes.
Area of Science:
- Pharmacology
- Biostatistics
- Clinical Trial Design
Background:
- Drug administration timing significantly influences pharmacokinetics (PK), affecting drug efficacy and toxicity.
- Optimizing dose and schedule is essential for maximizing therapeutic benefit and minimizing adverse events.
Purpose of the Study:
- To develop a Bayesian framework for identifying optimal drug dose-schedule regimens.
- To integrate pharmacokinetic, toxicity, and efficacy data for comprehensive treatment optimization.
Main Methods:
- Proposed a Bayesian PK integrated dose-schedule finding (PKIDS) design.
- Jointly modeled dose, concentration, toxicity, and efficacy using a Bayesian hierarchical model.
- Employed adaptive randomization for continuous updating and decision-making based on interim data.
Main Results:
- The PKIDS design effectively integrates PK, toxicity, and efficacy data.
- Demonstrated the ability to quantify risk-benefit profiles for different regimens.
- Simulation studies confirmed desirable operating characteristics of the proposed design.
Conclusions:
- The PKIDS design offers a robust method for optimizing drug dose-schedule regimens.
- Integrating PK data into adaptive trial designs enhances treatment personalization.
- This approach holds promise for improving drug development and clinical practice.
Related Concept Videos
01:19Nonlinear Pharmacokinetics: Overview
311
Nonlinear or dose-dependent pharmacokinetics is a phenomenon that occurs when the pharmacokinetic parameters of certain drugs deviate from linear pharmacokinetics at higher doses. These drugs do not follow the expected first-order kinetics, where the rate of drug elimination is directly proportional to the drug concentration. Instead, they exhibit a nonlinear relationship, which can be attributed to several factors.
Nonlinearity can arise due to the saturation of plasma protein-binding or...
Nonlinearity can arise due to the saturation of plasma protein-binding or...
311
01:15Drug Dosage Regimen: Overview
3.5K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.5K
01:12Analysis of Population Pharmacokinetic Data
240
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
240
01:26Pharmacokinetic Models: Comparison and Selection Criterion
50
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
50
01:23Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
103
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
103
01:22Nonlinear Pharmacokinetics: Bioavailability and Protein-Drug Binding
141
When a drug follows nonlinear pharmacokinetics, its bioavailability, the amount of the drug that reaches the systemic circulation, can change with different doses. This is due to the presence of a saturable pathway. The pathway becomes saturated as the drug concentration increases, decreasing the absorption rate. Consequently, the drug's bioavailability may be lower than expected at higher doses.
To quantify the extent of bioavailability, pharmacologists often use a parameter called .
To quantify the extent of bioavailability, pharmacologists often use a parameter called .
141